InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Its system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells. Founded in 2006, we are a Houston-headquartered, privately held company that was formed to innovate cell-based technologies for health care and life science research. The work of our scientists and doctors in the field of the stem and regenerative cell research has enabled us to develop a regenerative cell therapy product platform for multiple potential applications. This work has yielded numerous peer-reviewed publications and studies on the use of autologous adult stem cells - those that are extracted from and reintroduced into the same person - to promote healing.The average employee at InGeneron makes $52,224 per year. Pay at InGeneron is significantly lower than some of its highest paying competitors, like Gilead Sciences, Acorda Therapeutics, and Medivation, which pay $99,828, $97,279, and $94,135, respectively.Based in Houston, TX, InGeneron is a small health care company with only 32 employees and an annual revenue of $4.4M.
In demand companies are hiring! Let Zippi apply for you!
The founders of InGeneron is He Completed His Education At Technical University of Munich In Internal Medicine/Cardiology. Eckhard U. Alt Is Professor of Medicine and Biomedical Engineering At Tulane University In New Orleans and Was Professor of Medicine At University of Texas Anderson Cancer Center In Houston and At Technical University of Munich. He Received His Medical Degree As Valedictorian From Heidelberg Medical School. After Two Years In Cardiac Surgery At the Ludwig-Maximilians-University Munich M.D..
The key people at InGeneron are Angelo Moesslang and He Completed His Education At Technical University of Munich In Internal Medicine/Cardiology. Eckhard U. Alt Is Professor of Medicine and Biomedical Engineering At Tulane University In New Orleans and Was Professor of Medicine At University of Texas Anderson Cancer Center In Houston and At Technical University of Munich. He Received His Medical Degree As Valedictorian From Heidelberg Medical School. After Two Years In Cardiac Surgery At the Ludwig-Maximilians-University Munich M.D..
Key people
Angelo Moesslang
He Completed His Education At Technical University of Munich In Internal Medicine/Cardiology. Eckhard U. Alt Is Professor of Medicine and Biomedical Engineering At Tulane University In New Orleans and Was Professor of Medicine At University of Texas Anderson Cancer Center In Houston and At Technical University of Munich. He Received His Medical Degree As Valedictorian From Heidelberg Medical School. After Two Years In Cardiac Surgery At the Ludwig-Maximilians-University Munich M.D.
InGeneron salaries
Average InGeneron salary
$52,224
yearly
$25.11 hourly
Updated March 14, 2024
Rate the InGeneron's inclusivity.
Do you work at InGeneron?
Did InGeneron's compensation package meet your expectations?
InGeneron financial performance
8.5
Performance score
Highest paying InGeneron competitors
Compare InGeneron salaries to competitors, including Gilead Sciences, Acorda Therapeutics, and Medivation. Employees at Gilead Sciences earn the highest average yearly salary of $99,828. The salaries at Acorda Therapeutics average $97,279 per year, and the salaries at Medivation come in at $94,135 per year.
Rank
Company
Average salary
Jobs
1
$99,828
0
2
$97,279
0
3
$94,135
0
4
$90,328
0
5
$71,489
0
6
$64,435
0
7
$49,176
0
8
$44,788
0
Are you an executive, HR leader, or brand manager at InGeneron?
Claiming and updating your company profile on Zippia is free and easy.
Zippia gives an in-depth look into the details of InGeneron, including salaries, political affiliations, employee data, and more, in order to inform job seekers about InGeneron. The employee data is based on information from people who have self-reported their past or current employments at InGeneron. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by InGeneron. The data presented on this page does not represent the view of InGeneron and its employees or that of Zippia.
InGeneron may also be known as or be related to InGeneron, InGeneron Inc, InGeneron, Inc. and Ingeneron, Inc.